James D. Swift - Jun 1, 2024 Form 4 Insider Report for Pediatrix Medical Group, Inc. (MD)

Role: Chief Executive Officer, Director
Signature: /s/ Mary Ann E. Moore, Attorney-in-Fact
Stock symbol: MD
Transactions as of: Jun 1, 2024
Transactions value $: $0
Form type: 4
Date filed: 6/4/2024, 05:00 PM
Previous filing: Mar 5, 2024
Next filing: Sep 3, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MD	Common Stock	Award	$0	+105K	+138.49%	$0.00	181K	Jun 1, 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on June 1, 2025, twenty-five percent (25%) of the restricted shares will vest on June 1, 2026 and fifty percent (50%) of the restricted shares will vest on June 1, 2027, subject to the terms of the Plan.

Content

Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on June 1, 2025, twenty-five percent (25%) of the restricted shares will vest on June 1, 2026 and fifty percent (50%) of the restricted shares will vest on June 1, 2027, subject to the terms of the Plan.